PMPRB calls two (2) new hearings

PMPRB calls two (2) new hearings:

Penlac Nail Lacquer Hearing: The Patented Medicine Prices Review Board issued a Notice of Hearing in the matter of the company Sanofi-Aventis and its medicine Penlac Nail Lacquer. Penlac Nail Lacquer is indicated as part of a comprehensive nail management program in immunocompetent patients with mild to moderate onychomycosis (due to T. rubrum) of fingernails and toenails without lunula involvement. For more details, visit the following link http://www.pmprb-cepmb.gc.ca/english/view.asp?x=271&id=85 . The pre - hearing conference is set for June 6, 2007 and the hearing is to begin July 23, 2007.

Pentacel & Quadracel Hearing: The Patented Medicine Prices Review Board issued a Notice of Hearing in the matter of the company Sanofi Pasteur Ltd. and its medicines Pentacel & Quadracel. Pentacel is indicated for the primary immunization of infants, at or above the age of 2 months, and as a booster in children up to their 7th birthday against invasive disease caused by H. influenzae type b, diphtheria, tetanus, whooping cough and poliomyelitis in a single injection at a single visit when these vaccines are indicated. Quadracel is indicated for the primary immunization of infants, at or above the age of two months and as a booster in children up to their 7th birthdays against diphtheria, tetanus, whooping cough and poliomyelitis. For more details, visit the following link: http://www.pmprb-cepmb.gc.ca/english/view.asp?x=271&id=86 . The pre - hearing conference is set for June 25, 2007 and the hearing is to begin August 20, 2007.